Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

3.13
Delayed Data
As of Jun 24
 -0.19 / -5.72%
Today’s Change
3.12
Today|||52-Week Range
19.43
-76.93%
Year-to-Date
Why ImmunoGen, Inc. Noted a Lower Price Today
Jun 14 / MotleyFool.com - Paid Partner Content
Why is ImmunoGen (IMGN) Stock Down Today?
Jun 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.32
Today’s open3.19
Day’s range3.12 - 3.28
Volume1,524,752
Average volume (3 months)1,751,039
Market cap$272.6M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.62%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book7.72

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...-0.62-6.32%
NSTGNanoString Technolog...-1.14-8.03%
BTXBioTime Inc-0.10-4.08%
ONVOOrganovo Holdings In...-0.10-2.90%
Data as of 4:06pm ET, 06/24/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs